US Patent Issued to PHARMA CINQ on March 17 for "2',3'-diacetyluridine substituted with acetoacetyl at the 5' position" (Maryland Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,577,270, issued on March 17, was assigned to PHARMA CINQ LLC (Rockville, Md.).

"2',3'-diacetyluridine substituted with acetoacetyl at the 5' position" was invented by Reid Warren Von Borstel (Potomac, Md.), David Michael Simpson (North Bethesda, Md.) and Rolando Alejandro Garcia Garcia (Germantown, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "5'-O-(Acetoacetyl)-2',3'-di-O-acetyluridine is useful in the treatment or prevention of disorders characterized by cerebral metabolic energy failure or diminished mitochondrial energy reserve capacity."

The patent was filed on Sept. 14, 2021, under Application No. 18/021,907.

*For further information, incl...